Navigation Links
Regulatory T-cells – Protector or Cause of Diseases

Immune system protects the body from infection causing agents. Regulatory T-cells, a part of the immune system, learn in early stages of life itself to recognize// the invaders and defend them. But, researchers have reported that these cells seem to protect certain bacteria, viruses and tumors.

Researchers at the Medical college of Georgia, studied the T-cells in the thymus and their subsequent movement in the body, using a genetically manipulated mice and the technology enabling the detection of antigen receptors. These antigen receptors determine what the T-cells recognize.

They found regulatory T cells learn what to protect while in the thymus and that everything the cells learn may not be good, according to research in the August issue of Immunity.

It is widely believed that regulatory T cells only recognize endogenous body tissue so they can stop T cells that are predisposed to attacking it, says Dr. Leszek Ignatowicz, MCG immunologist and the study’s corresponding author.

By examining receptors on all types of T cells before and after they leave the thymus, researchers found regulatory T cells are very diverse and able to recognize endogenous tissue and invaders, Dr. Ignatowicz says.

Unfortunately, the cells also may not learn to recognize all endogenous tissue which, along with environmental and other factors, can lead to autoimmune disease.

T cell schooling in the thymus peaks in the first six weeks of life in the mouse, which roughly translates to the first 15 years of human life. Those early lessons seem to last a lifetime and the few regulatory cells that develop later will be like the early cells, says Dr. Rafal Pacholczyk, MCG immunologist and lead author.

The findings mean, essentially from the beginning, some people may have regulatory T cells less skilled at keeping the immune system from attacking their bodies and/or too skilled at protecting invaders.

I t also means one day physicians might steer early education of regulatory T cells in the thymus as a way to vaccinate children against diseases such as lupus, arthritis and type 1diabetes. Or, they might add regulatory T cells to improve the mix in people who already have some bad police.

“We need some of the regulatory cells more than others,” says Dr. Ignatowicz. “We probably need more of the ones that recognize autoantigens on the pancreas and we need the ones that recognize tumors to be less frequent.”

The fact that most regulatory T cells in the body come directly from the thymus, not from other circulating T cells, also was previously unknown, Dr. Pacholczyk says. “Where they come from is the main question we wanted to answer,” says Dr. Ignatowicz.

It has been thought that some T cells circulating in the body might make the transformation, possibly because of what they are exposed to in the body. In fact T cells most aggressive at attacking endogenous tissue likely would be among those converting to protective regulatory cells, Dr. Ignatowicz says. “We did not find that does not happen, but it’s not the major mechanism for generating regulatory cells in the body,” Dr. Pacholczyk says.

All T cells are made in the bone marrow then move to the thymus as progenitor cells where they differentiate, upregulating surface receptors, which are molecules that detect different antigens. It’s a brutal process – 95 percent of the cells die in the thymus primarily because they recognize body tissue – that winds down after puberty.

All T cells wear their receptors for life, like signature hats. “We decided to compare receptors on the regulatory cells in the periphery with those in the thymus,” says Dr. Pacholczyk. By analyzing receptors on individual cells, they were able to follow the cells after they left the thymus and see if they changed.

Another key question was how regulatory T cells, which make u p about 5 percent of the total T cell population, can control millions of roaming T cells. They found it was a simple matter of numbers: by wearing many hats, or antigen receptors, regulatory T cells can keep their eyes on a lot of different non-regulatory cells.

“The next question we will ask, which is a hot topic right now, is what antigens trigger receptors on regulatory T cells?” says Dr. Pacholczyk. “What do they recognize? We know now they are coming from the thymus but how they are being generated is still a question. We want to look into the nature of antigens those receptors recognize which will allow us to predict more how they are being developed in the tymus.”


'"/>




Related medicine news :

1. Tumor Suppressor p53s Contradictory Regulatory System
2. Human Complexity Can Be Attributed To Regulatory Sequence
3. The Lancet Calls For Review Of Regulatory Process Of Drug Trials
4. Medtronic’s Insulin Pump Receives Regulatory Approva
5. GMC Wrestles For Regulatory Powers
6. Regulatory Mechanism for Tumor Suppressor Protein Identified
7. Structure of Iron Regulatory Protein-RNA Complex Solved
8. Ramadoss Vows to Set Up Food Regulatory Body in India
9. Master Regulatory Gene of Epithelial Stem Cells Identified
10. T-cells Developed from Human Embryonic Stem Cells
11. Is Diabetes the Leading Cause of Kidney Failure in India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by patients ... having low level of oxygen in their blood ... are to be used only with prescription and ... concentrators work either on rechargeable lithium batteries or ...
(Date:2/21/2017)...   BeyondSpring Pharmaceuticals , a clinical stage ... immuno-oncology cancer therapies, today announced that the Company,s ... 2 trial of BeyondSpring,s innovative lead asset, ... lung cancer (NSCLC) with Docetaxel has been selected ... Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: